RxSight(US:RXST) Globenewswire·2025-09-22 14:03Core Viewpoint - A class action lawsuit has been filed against RxSight, Inc. for allegedly making false or misleading statements regarding its financial performance and product demand during the specified class period [7]. Allegation Details - The lawsuit claims that RxSight faced "adoption challenges" and structural issues leading to declines in sales and utilization [7]. - It is alleged that the company overstated the demand for its products and was unlikely to meet its previously issued financial guidance for fiscal year 2025 [7]. - Following the release of preliminary financial results on July 8, 2025, which showed significant declines in Light Delivery Device (LDD) sales and overall revenue, RxSight lowered its full-year guidance by approximately $42.5 million at the midpoint [7]. Financial Impact - The lawsuit indicates that RxSight's stock price fell nearly 38% after the announcement of disappointing financial results and guidance adjustments [7].